Back
Cullinan Therapeutics Stock Price Chart
Sponsored
CGEM
Sponsored
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge
Buy
59
CGEM
Cullinan Therapeutics
Last Price:
26.39
Seasonality Move:
13.37%
7 Day Trial
ALL ACCESS PASS
$
7
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.- The current trend is moderately bullish and CGEM is experiencing selling pressure, which indicates risk of future bearish movement.
Cullinan Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.66 | Sell |
20-day SMA: | 23.41 | Buy |
50-day SMA: | 19.47 | Buy |
200-day SMA: | 13.11 | Buy |
8-day EMA: | 26.75 | Sell |
20-day EMA: | 24.34 | Buy |
50-day EMA: | 20.71 | Buy |
200-day EMA: | 15.02 | Buy |
Cullinan Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.67 | Buy |
Relative Strength Index (14 RSI): | 62.99 | Buy |
Chaikin Money Flow: | -643686 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.93 - 27.29) | Buy |
Bollinger Bands (100): | (11.81 - 21.69) | Buy |
Cullinan Therapeutics Technical Analysis
Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cullinan Therapeutics Stock
Is Cullinan Therapeutics Stock a Buy?
- Cullinan Therapeutics share price is 26.13 while CGEM 8-day simple moving average is 27.66, which is a Sell signal.
- The stock price of CGEM is 26.13 while Cullinan Therapeutics 20-day SMA is 23.41, which makes it a Buy.
- Cullinan Therapeutics 50-day simple moving average is 19.47 while CGEM share price is 26.13, making it a Buy technically.
- CGEM stock price is 26.13 and Cullinan Therapeutics 200-day simple moving average is 13.11, creating a Buy signal.
CGEM Technical Analysis vs Fundamental Analysis
Buy
59
Cullinan Therapeutics (CGEM)
is a Buy
Is Cullinan Therapeutics a Buy or a Sell?
-
Cullinan Therapeutics stock is rated a Buy
The current Cullinan Therapeutics [CGEM] share price is $26.13. The Score for CGEM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Cullinan Therapeutics Stock Info
Market Cap:
1.13B
Price in USD:
26.13
Share Volume:
698.47K
Cullinan Therapeutics 52-Week Range
52-Week High:
30.19
52-Week Low:
7.64
Buy
59
Cullinan Therapeutics (CGEM)
is a Buy
Cullinan Therapeutics Share Price Forecast
-
What is the Cullinan Therapeutics stock price today?
The Cullinan Therapeutics stock price is 26.13 USD today. -
Will CGEM stock go up or go down?
Cullinan Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cullinan Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cullinan Therapeutics is not overvalued.
Is Cullinan Therapeutics Stock a Buy?
- Cullinan Therapeutics share price is 26.13 while CGEM 8-day exponential moving average is 26.75, which is a Sell signal.
- The stock price of CGEM is 26.13 while Cullinan Therapeutics 20-day EMA is 24.34, which makes it a Buy.
- Cullinan Therapeutics 50-day exponential moving average is 20.71 while CGEM share price is 26.13, making it a Buy technically.
- CGEM stock price is 26.13 and Cullinan Therapeutics 200-day simple moving average is 15.02, creating a Buy signal.
Fundamental Analysis of Cullinan Therapeutics
Is Cullinan Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.57 per share, and an increase next year of $0.23 per share.
Technical Analysis of Cullinan Therapeutics
Should I short Cullinan Therapeutics stock?
- CGEM Moving Average Covergence Divergence (MACD) indicator is 2.67, suggesting Cullinan Therapeutics is a Buy
- Cullinan Therapeutics Relative Strength Index (RSI) is 62.99, which suggest Cullinan Therapeutics is overbought
- The Bollinger Bands (25) for Cullinan Therapeutics is (16.93 - 27.29), which suggest Cullinan Therapeutics is a Buy
- The Bollinger Bands (100) for Cullinan Therapeutics is (11.81 - 21.69), which suggest Cullinan Therapeutics is a Buy
* Cullinan Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.